Genomics

Dataset Information

0

MiRNA expression variation in primary NK cells treated with TGF-β1


ABSTRACT: Human NK cells activity against cancer cells is deeply suppressed by TGF-β1, an immunomodulatory cytokine that is released and activated in the tumor microenvironment. Moreover, our previous data showed that TGF-β1 modifies the chemokine receptor repertoire of NK cells. In particular, it decreases the expression of CX3CR1 that drives these effectors toward peripheral tissues, including tumor sites. In order to identify possible mechanisms mediating chemokine receptors modulation, we analyzed the miRNA profile of TGF-β1-treated primary NK cells. The analysis pointed out miR-27a-5p as a possible modulator of CX3CR1. We demonstrated the functional interaction of miR-27a-5p with the 3’ untranslated region (3’UTR) of CX3CR1 mRNA by two different experimental approaches: by the use of a luciferase assay based on a reporter construct containing the CX3CR1 3’UTR and by transfection of primary NK cells with a miR-27a-5p inhibitor. We also showed that the TGF-β1-mediated increase of miR-27a-5p expression is a consequence of miR-23a-27a-24-2 cluster induction. Moreover, we demonstrated that miR-27a-5p down-regulates the surface expression of CX3CR1. Finally we showed that Neuroblastoma cells induced in resting NK cells a downregulation of the CX3CR1 expression that was paralleled by a significant increase of miR-27a-5p expression. Therefore, the present study highlights miR-27a-5p as a pivotal TGF-β1-induced regulator of CX3CR1 expression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE98769 | GEO | 2017/05/11

SECONDARY ACCESSION(S): PRJNA386164

REPOSITORIES: GEO

Similar Datasets

2023-04-01 | GSE226758 | GEO
| E-GEOD-34475 | biostudies-arrayexpress
| E-GEOD-48006 | biostudies-arrayexpress
2020-01-31 | PXD016915 | Pride
2017-03-08 | GSE95766 | GEO
2012-03-01 | GSE34475 | GEO
2021-03-27 | GSE169717 | GEO
2020-10-20 | GSE158571 | GEO
2013-10-30 | GSE51828 | GEO
2020-07-03 | GSE136956 | GEO